Teva Pharmaceutical Industries (TEVA) Change in Working Capital (2025 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded quarterly Change in Working Capital of -$617.0 million in Q1 2026, up 11.86% on a QoQ basis from -$700.0 million in Q1 2025, and up 11.86% year-over-year from -$551.6 million in Q1 2025.
Teva Pharmaceutical Industries (TEVA) Change in Working Capital (2025 - 2026) Analysis & Trends
Teva Pharmaceutical Industries has disclosed Change in Working Capital across 2 years of filings, most recently posting -$617.0 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.52 Bn | 35.79 Bn | 1.97 Bn | -617.00 Mn |
| 2 | Zoetis | 33.53 Bn | 31.59 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.92 Bn | 21.77 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.96 Bn | 16.88 Bn | 33.43 Mn | 215.05 Mn |
| 5 | Neurocrine Biosciences | 16.47 Bn | 15.15 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.76 Bn | 11.33 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.11 Bn | 6.60 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.53 Bn | 6.03 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 5.98 Bn | 5.23 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.44 Bn | 5.22 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -617.00 Mn |
| Mar 31, 2026 | -617.00 Mn |
| Mar 31, 2025 | -700.00 Mn |
| Mar 31, 2025 | -700.00 Mn |